Eli Lilly and Company

Pharmareferent Cardiometabolic Health (m/w/d) Gebiet: Leipzig, Schkeuditz, Merseburg, Weißenfels, Hohenmölsen (5116011)

Germany

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess a scientific education (ideally a university degree) or training as a Qualified Pharmaceutical Representative, with a minimum of two years of professional experience as a Pharmaceutical Representative, including knowledge of diabetes and cardiology, and experience in practices and clinics. Strong sales skills, a goal-oriented approach, high social and teamwork skills, networking skills, and effective digital IT skills are required.

Responsibilities

The Pharmareferent Cardiometabolic Health will conduct sales conversations with specialist groups in practices, clinics, and pharmacies, utilizing digital communication channels, implement sales and marketing strategies, develop and implement area action plans and contact scheduling, organize and conduct training events, including digital events, and contribute to the organization of events and workshops.

Skills

Sales skills
Goal-oriented
Social skills
Teamwork
Networking
Digital IT skills
Communication channels

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI